AR012181A1 - Un derivado de pirimidina, procedimientos para prepararlo, una composicion farmaceutica que lo comprende, y un compuesto util como intermediario parapreparar dicho derivado de pirimidina. - Google Patents

Un derivado de pirimidina, procedimientos para prepararlo, una composicion farmaceutica que lo comprende, y un compuesto util como intermediario parapreparar dicho derivado de pirimidina.

Info

Publication number
AR012181A1
AR012181A1 ARP980101380A ARP980101380A AR012181A1 AR 012181 A1 AR012181 A1 AR 012181A1 AR P980101380 A ARP980101380 A AR P980101380A AR P980101380 A ARP980101380 A AR P980101380A AR 012181 A1 AR012181 A1 AR 012181A1
Authority
AR
Argentina
Prior art keywords
methyl
hydrogen
substituted
formula
pirimidine
Prior art date
Application number
ARP980101380A
Other languages
English (en)
Spanish (es)
Original Assignee
Yuhan Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp filed Critical Yuhan Corp
Publication of AR012181A1 publication Critical patent/AR012181A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP980101380A 1997-03-27 1998-03-26 Un derivado de pirimidina, procedimientos para prepararlo, una composicion farmaceutica que lo comprende, y un compuesto util como intermediario parapreparar dicho derivado de pirimidina. AR012181A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR19970010863 1997-03-27
KR19970010862 1997-03-27

Publications (1)

Publication Number Publication Date
AR012181A1 true AR012181A1 (es) 2000-09-27

Family

ID=26632616

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101380A AR012181A1 (es) 1997-03-27 1998-03-26 Un derivado de pirimidina, procedimientos para prepararlo, una composicion farmaceutica que lo comprende, y un compuesto util como intermediario parapreparar dicho derivado de pirimidina.

Country Status (21)

Country Link
US (1) US6352993B1 (en:Method)
EP (1) EP1015444B1 (en:Method)
JP (1) JP3176379B2 (en:Method)
KR (1) KR100278857B1 (en:Method)
CN (1) CN1118464C (en:Method)
AR (1) AR012181A1 (en:Method)
AT (1) ATE241613T1 (en:Method)
AU (1) AU720385B2 (en:Method)
BR (1) BR9808070A (en:Method)
CA (1) CA2284795C (en:Method)
DE (1) DE69815126T2 (en:Method)
DK (1) DK1015444T3 (en:Method)
ES (1) ES2200324T3 (en:Method)
HU (1) HUP0000851A3 (en:Method)
IN (1) IN188411B (en:Method)
PT (1) PT1015444E (en:Method)
RU (1) RU2203894C2 (en:Method)
TR (1) TR199902383T2 (en:Method)
TW (1) TW542831B (en:Method)
UY (1) UY24938A1 (en:Method)
WO (1) WO1998043968A1 (en:Method)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
AR038368A1 (es) 2002-02-01 2005-01-12 Novartis Ag Compuestos n-pirimidin-2-il-aminas sustituidas como inhibidores de ige, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de un medicamento
EP1534278A4 (en) 2002-08-01 2006-09-06 Nitromed Inc NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
JP2006528640A (ja) * 2003-07-22 2006-12-21 ニューロジェン・コーポレーション 置換ピリジン−2−イルアミン類縁体
WO2005039506A2 (en) * 2003-10-24 2005-05-06 Exelixis, Inc. P70s6 kinase modulators and method of use
US20080280944A1 (en) 2003-11-03 2008-11-13 Paula Fernstrom Imidazo[1,2-A]Pyridine Derivatives For The Treatment Of Silent Gastro-Esophageal Reflux
KR101122376B1 (ko) * 2005-03-09 2012-03-26 주식회사유한양행 신규의 5,6-다이메틸피리미딘 유도체 및 그의 제조방법
US20090124645A1 (en) * 2005-10-14 2009-05-14 Neurosearch A/S Novel Pyrimidine-2,4-Diamine Derivatives and their Use as Modulators of Small-Conductance Calcium-Activated Potassium Channels
JP4946482B2 (ja) 2007-02-08 2012-06-06 船井電機株式会社 緩衝用梱包材及びtv受像機の緩衝用梱包材
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
MY153606A (en) 2008-08-05 2015-02-27 Daiichi Sankyo Co Ltd Imidazopyridin-2-one derivatives
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
MX2013005478A (es) 2010-11-15 2013-08-29 Univ Leuven Kath Compuestos heterociclicos condensados antivirales.
JP5980236B2 (ja) 2011-02-25 2016-08-31 ユーハン・コーポレイションYUHAN Corporation ジアミノピリミジン誘導体及びその製造方法
EP2836486B1 (en) * 2012-02-17 2017-10-04 AbbVie Inc. Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (rsv)
KR102080782B1 (ko) 2012-05-29 2020-02-27 모멘티브 퍼포먼스 머티리얼즈 게엠베하 이소시아네이토 실란의 제조
NZ708909A (en) 2012-11-21 2019-11-29 Ptc Therapeutics Inc Substituted reverse pyrimidine bmi-1 inhibitors
MX2015011898A (es) 2013-03-13 2016-05-05 Genentech Inc Compuestos de pirazolo y usos de los mismos.
EP3039015B1 (en) 2013-08-30 2019-10-30 PTC Therapeutics, Inc. Substituted pyrimidine bmi-1 inhibitors
EP3055301B1 (en) * 2013-10-07 2019-11-20 Kadmon Corporation, LLC (2-(5-isoindolin-2-yl)pyrimidin-4-yl)-amine derivatives as rho kinase inhibitors for treating autoimmune diseases
EP3071553A4 (en) 2013-11-21 2017-08-02 PTC Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors
CN107206004A (zh) 2014-10-22 2017-09-26 德克萨斯大学系统董事会 靶向盘状结构域受体1的小分子抑制剂及其用途
CN105669642B (zh) * 2014-11-19 2020-06-09 江苏天士力帝益药业有限公司 一种盐酸洛氟普啶的制备方法
UA125377C2 (uk) * 2016-01-04 2022-03-02 Мерк Сероно С.А. L-валінат карбоксамідного похідного гідроксипропілтіазолідину та його сольова форма, кристалічна поліморфна форма
CN110461833A (zh) * 2017-04-05 2019-11-15 拜耳作物科学股份公司 2-氨基-5-氧基烷基嘧啶衍生物及其用于防治不希望的植物生长的用途
AU2019340402B2 (en) 2018-08-17 2025-04-03 Ptc Therapeutics, Inc. Method for treating pancreatic cancer
CN114685369B (zh) * 2022-05-17 2024-02-02 河南省科学院高新技术研究中心 一种利用离子液体制备1-甲基-1,2,3,4-四氢异喹啉的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000138A (en) 1966-03-31 1976-12-28 Imperial Chemical Industries Limited Organic compounds and compositions containing them
GB1182584A (en) 1966-03-31 1970-02-25 Ici Ltd Pyrimidine derivates and the use thereof as fungicides
US3980781A (en) 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
US4044136A (en) 1972-09-09 1977-08-23 Pfizer Inc. Aminoquinazoline therapeutic agents
GB1383409A (en) 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US3956495A (en) 1973-10-30 1976-05-11 Eli Lilly And Company 2,4-Diaminoquinazolines as antithrombotic agents
US4755218A (en) 1985-12-31 1988-07-05 Monsanto Company Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
IL88507A (en) * 1987-12-03 1993-02-21 Smithkline Beckman Intercredit 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
US4966622A (en) 1988-04-12 1990-10-30 Ciba-Geigy Corporation N-phenyl-N-pyrimidin-2-ylureas
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
DE3901448A1 (de) 1989-01-19 1990-07-26 Basf Ag Emulsionscopolymerisate
ES2081863T3 (es) 1989-03-22 1996-03-16 Ciba Geigy Ag Plaguicidas.
GB8910722D0 (en) 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
CA2015981A1 (en) * 1989-05-10 1990-11-10 Thomas H. Brown Compounds
GB9012592D0 (en) 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
ATE124694T1 (de) 1990-11-06 1995-07-15 Pfizer Chinazolinderivate um die antitumorwirkung zu verbessern.
HUT65177A (en) 1991-04-17 1994-05-02 Pfizer Process for producing antitumor activity enhancing pyrimidine derivatives and pharmaceutical preparations containing them
US5276186A (en) 1992-03-11 1994-01-04 Ciba-Geigy Corporation Process for the production of guanidine derivatives
KR0144833B1 (ko) * 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
DE69432019T2 (de) * 1993-08-12 2003-11-27 Astrazeneca Ab, Soedertaelje Amidin-derivate mit stickstoffoxid-synthease-aktivität
DE69408750T2 (de) 1993-08-26 1998-07-23 Ono Pharmaceutical Co 4-Aminopyrimidin Derivate
RU2153494C2 (ru) 1993-10-12 2000-07-27 Дзе Дюпон Мерк Фармасьютикал Компани 1-n-алкил-n-арилпиримидинамины, способ лечения заболеваний, фармацевтическая композиция
WO1996005177A1 (en) 1994-08-13 1996-02-22 Yuhan Corporation Novel pyrimidine derivatives and processes for the preparation thereof
AU712970B2 (en) * 1996-05-04 1999-11-18 Yuhan Corporation Process for preparation of pyrimidine derivatives

Also Published As

Publication number Publication date
HUP0000851A1 (hu) 2001-04-28
RU2203894C2 (ru) 2003-05-10
KR19980080789A (ko) 1998-11-25
WO1998043968A1 (en) 1998-10-08
AU720385B2 (en) 2000-06-01
CN1118464C (zh) 2003-08-20
JP3176379B2 (ja) 2001-06-18
EP1015444A1 (en) 2000-07-05
AU6523998A (en) 1998-10-22
UY24938A1 (es) 2001-01-31
EP1015444B1 (en) 2003-05-28
CA2284795A1 (en) 1998-10-08
CA2284795C (en) 2004-01-20
PT1015444E (pt) 2003-10-31
ATE241613T1 (de) 2003-06-15
DK1015444T3 (da) 2003-08-18
DE69815126T2 (de) 2004-04-08
ES2200324T3 (es) 2004-03-01
JP2000513014A (ja) 2000-10-03
TR199902383T2 (xx) 2000-06-21
BR9808070A (pt) 2000-03-08
CN1251586A (zh) 2000-04-26
US6352993B1 (en) 2002-03-05
KR100278857B1 (ko) 2001-01-15
TW542831B (en) 2003-07-21
IN188411B (en:Method) 2002-09-21
DE69815126D1 (de) 2003-07-03
HUP0000851A3 (en) 2002-04-29
HK1026418A1 (en) 2000-12-15

Similar Documents

Publication Publication Date Title
AR012181A1 (es) Un derivado de pirimidina, procedimientos para prepararlo, una composicion farmaceutica que lo comprende, y un compuesto util como intermediario parapreparar dicho derivado de pirimidina.
AR038883A1 (es) Compuestos que modulan la actividad de ppar, composicion farmaceutica que los contiene y un metodo para prepararlos
AR029301A1 (es) Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos
PE20020566A1 (es) DERIVADOS DE FENILACETAMIDO-PIRAZOLES COMO INHIBIDORES DE LA cdk/CICLINA QUINASA
PE20040155A1 (es) Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen
PE20010482A1 (es) Derivados de 3-ureido-pirazol y procedimiento para su preparacion
AR036046A1 (es) Inhibidores de la hiv proteasa, composiciones que las contienen y sus usos farmaceuticos
AR019427A1 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa, procedimiento para su preparacion, su uso para la preparacion de medicamentos, composiciones farmaceuticas y compuestos intermediarios utiles para su preparacion
EA200401172A1 (ru) Производные n-[фенил(пиперидин-2-ил)метил]бензамида, способ их получения и их применение в терапии
CO5011090A1 (es) Derivados de acil-piperazinil-pirimidinas, procedimiento para su preparacion y composiciones farmaceuticas de los mismos
EA200200942A1 (ru) Фармацевтические композиции, содержащие производные 3-аминоазетидина, новые производные и способ их получения
BR0108378A (pt) Sal cristalino de um composto, composição farmacêutica, processo para a manufatura do dito sal, e, uso do mesmo
EA202090658A1 (ru) Ингибиторы кэп-зависимой эндонуклеазы
DK0704448T3 (da) Nye imidazolidiner substitueret med en heterocyklisk forbindelse, fremgangsmåde og mellemprodukter til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
PE20070829A1 (es) Inhibidores cetp heterociclicos
BR9102322A (pt) Derivados de morfolino-ureia,processo para sua preparacao,composicoes inseticidas e acaricidas,processo para o combate de insetos e acaros,utilizacao e processo para a preparacao de composicoes
SE9703377D0 (sv) New compounds
CO4770955A1 (es) Acidos 4-amino-2-heterobiciclo [3.1.0] hexano -4,6- dicarboxilicos
AR042362A1 (es) Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen
ES2032384T3 (es) Procedimiento para preparar derivados de carboxamidas.
DK425382A (da) Fremgangsmaade til fremstilling af amider
AR024222A1 (es) Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
BRPI0516748B8 (pt) pirimidinas 5-substituídas inibidoras de hiv e composição farmacêutica que as compreende
ES2012648A6 (es) Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina.
YU13899A (sh) Pirolidinil i pirolinil etilaminska jedinjenja kao kapa agonisti

Legal Events

Date Code Title Description
FB Suspension of granting procedure